Dabur Research Foundation - Revision history

UpdateBot: robot: Update article (please report if you notice any mistake or error in this edit)

2022-05-24T20:53:00Z

robot: Update article (please report if you notice any mistake or error in this edit)

← Older revision		Revision as of 02:23, 25 May 2022
Line 21:		Line 21:
	==References==		==References==
	{{Reflist}}		{{Reflist}}
	* [http://articles.economictimes.indiatimes.com/keyword/international-finance-corporation Articles about International Finance Corporation - Economic Times<!-- Bot generated title -->]		* [http://articles.economictimes.indiatimes.com/keyword/international-finance-corporation Articles about International Finance Corporation – Economic Times<!-- Bot generated title -->]
	* [https://web.archive.org/web/20111102220924/http://biospectrumindia.ciol.com/content/CoverStory/111101113.asp BioSpectrumIndia - the business of biotech - Customer relationships in a competitive market<!-- Bot generated title -->]		* [https://web.archive.org/web/20111102220924/http://biospectrumindia.ciol.com/content/CoverStory/111101113.asp BioSpectrumIndia – the business of biotech – Customer relationships in a competitive market<!-- Bot generated title -->]
	* [http://www.business-standard.com/india/news/elephant-capital-buys-stake-in-clintec-intl-for-rs-58-cr/105952/on Elephant Capital buys stake in ClinTec Intl for Rs 58 cr<!-- Bot generated title -->]		* [http://www.business-standard.com/india/news/elephant-capital-buys-stake-in-clintec-intl-for-rs-58-cr/105952/on Elephant Capital buys stake in ClinTec Intl for Rs 58 cr<!-- Bot generated title -->]
	* [https://web.archive.org/web/20120827052720/http://www.biospectrumasia.com/biospectrum/opinion/3204/cosmetics-testing-kills-million-animals#.UEuw9rLiZi9 Cosmetics testing kills 3.9 million animals - BioSpectrum Asia<!-- Bot generated title -->]		* [https://web.archive.org/web/20120827052720/http://www.biospectrumasia.com/biospectrum/opinion/3204/cosmetics-testing-kills-million-animals#.UEuw9rLiZi9 Cosmetics testing kills 3.9 million animals - BioSpectrum Asia<!-- Bot generated title -->]
Line 28:		Line 28:
	* [http://www.business-standard.com/india/news/dabur-to-re-expand-its-pharma-research/382968/ Dabur to re-expand its pharma research<!-- Bot generated title -->]		* [http://www.business-standard.com/india/news/dabur-to-re-expand-its-pharma-research/382968/ Dabur to re-expand its pharma research<!-- Bot generated title -->]

	==~~Further reading~~==		==Review of Literature ==
	* {{cite journal \|doi=10.1007/s12094-012-0883-2 \|title=Efficiency and mechanism of intracellular paclitaxel delivery by novel nanopolymer-based tumor-targeted delivery system, Nanoxel \|year=2012 \|last1=Madaan \|first1=Alka \|last2=Singh \|first2=Pratibha \|last3=Awasthi \|first3=Anshumali \|last4=Verma \|first4=Ritu \|last5=Singh \|first5=Anu T. \|last6=Jaggi \|first6=Manu \|last7=Mishra \|first7=Shiva Kant \|last8=Kulkarni \|first8=Sadanand \|last9=Kulkarni \|first9=Hrishikesh \|journal=Clinical and Translational Oncology \|volume=15 \|issue=1 \|pages=26–32 \|pmid=22855169 }}		* {{cite journal \|doi=10.1007/s12094-012-0883-2 \|title=Efficiency and mechanism of intracellular paclitaxel delivery by novel nanopolymer-based tumor-targeted delivery system, Nanoxel \|year=2012 \|last1=Madaan \|first1=Alka \|last2=Singh \|first2=Pratibha \|last3=Awasthi \|first3=Anshumali \|last4=Verma \|first4=Ritu \|last5=Singh \|first5=Anu T. \|last6=Jaggi \|first6=Manu \|last7=Mishra \|first7=Shiva Kant \|last8=Kulkarni \|first8=Sadanand \|last9=Kulkarni \|first9=Hrishikesh \|journal=Clinical and Translational Oncology \|volume=15 \|issue=1 \|pages=26–32 \|pmid=22855169 }}
	* {{cite journal \|doi=10.1080/14756360802696802 \|title=Anticancer and immunomodulatory activities of novel 1,8-naphthyridine derivatives \|year=2009 \|last1=Kumar \|first1=Vivek \|last2=Madaan \|first2=Alka \|last3=Sanna \|first3=Vinod K. \|last4=Vishnoi \|first4=Manupriya \|last5=Joshi \|first5=Narendra \|last6=Singh \|first6=Anu T. \|last7=Jaggi \|first7=Manu \|last8=Sharma \|first8=Pramod K. \|last9=Irchhaiya \|first9=Raghuveer \|last10=Burman \|first10=Anand C. \|journal=Journal of Enzyme Inhibition and Medicinal Chemistry \|volume=24 \|issue=5 \|pages=1169–78 \|pmid=19555167\|display-authors=8 }}		* {{cite journal \|doi=10.1080/14756360802696802 \|title=Anticancer and immunomodulatory activities of novel 1,8-naphthyridine derivatives \|year=2009 \|last1=Kumar \|first1=Vivek \|last2=Madaan \|first2=Alka \|last3=Sanna \|first3=Vinod K. \|last4=Vishnoi \|first4=Manupriya \|last5=Joshi \|first5=Narendra \|last6=Singh \|first6=Anu T. \|last7=Jaggi \|first7=Manu \|last8=Sharma \|first8=Pramod K. \|last9=Irchhaiya \|first9=Raghuveer \|last10=Burman \|first10=Anand C. \|journal=Journal of Enzyme Inhibition and Medicinal Chemistry \|volume=24 \|issue=5 \|pages=1169–78 \|pmid=19555167\|display-authors=8 }}

>ZI Jony: v2.04b - Fix errors for CW project (Template contains useless word template:)

2021-08-12T16:53:06Z

v2.04b - Fix errors for CW project (Template contains useless word template:)

← Older revision		Revision as of 22:23, 12 August 2021
Line 8:		Line 8:

	{{Infobox company		{{Infobox company
	\| logo = Dabur Research Foundation ~~Logo~~.~~jpg~~		\| logo = Dabur Research Foundation logo.png
	\| name = Dabur Research Foundation		\| name = Dabur Research Foundation
	\| foundation = 1979		\| foundation = 1979
Line 36:		Line 36:
	* [http://www.daburresearch.in/ Official website]		* [http://www.daburresearch.in/ Official website]

	{{~~Template:~~Dabur Group}}		{{Dabur Group}}

	{{Authority control}}		{{Authority control}}

>Tharun S Yadla: Dabur group template added

2021-03-13T14:51:08Z

Dabur group template added

New page

{{Multiple issues|
{{notability|Org|date=December 2018}}
{{No footnotes|article|date=October 2012}}
}}

{{Use dmy dates|date=August 2018}}
{{Use Indian English|date=August 2018}}

{{Infobox company
| logo = Dabur Research Foundation Logo.jpg
| name = Dabur Research Foundation
| foundation = 1979
| location_city = Sahibabad, [[Ghaziabad, India|Ghaziabad]] - 201010 (UP)
| location_country = [[India]]
| parent = [[Dabur India Limited]]
| homepage = [http://www.daburresearch.in/ daburresearch.in]
}}

'''Dabur Research Foundation''' ('''DRF''') is an Indian contract research organization offering pre-clinical services in [[drug discovery]] and [[Drug development|development]]. It was established in 1979 to spearhead the research and development activities of [[Dabur]], [[India]]'s largest [[Ayurveda|Ayurvedic]] medicine manufacturer.

==References==
{{Reflist}}
* [http://articles.economictimes.indiatimes.com/keyword/international-finance-corporation Articles about International Finance Corporation - Economic Times]
* [https://web.archive.org/web/20111102220924/http://biospectrumindia.ciol.com/content/CoverStory/111101113.asp BioSpectrumIndia - the business of biotech - Customer relationships in a competitive market]
* [http://www.business-standard.com/india/news/elephant-capital-buys-stake-in-clintec-intl-for-rs-58-cr/105952/on Elephant Capital buys stake in ClinTec Intl for Rs 58 cr]
* [https://web.archive.org/web/20120827052720/http://www.biospectrumasia.com/biospectrum/opinion/3204/cosmetics-testing-kills-million-animals#.UEuw9rLiZi9 Cosmetics testing kills 3.9 million animals - BioSpectrum Asia]
* [http://www.business-standard.com/india/news/burmans-plan-rs-925-crore-healthcare-fund/386098/ Burmans plan Rs 925-crore healthcare fund]
* [http://www.business-standard.com/india/news/dabur-to-re-expand-its-pharma-research/382968/ Dabur to re-expand its pharma research]

==Further reading==
* {{cite journal |doi=10.1007/s12094-012-0883-2 |title=Efficiency and mechanism of intracellular paclitaxel delivery by novel nanopolymer-based tumor-targeted delivery system, Nanoxel |year=2012 |last1=Madaan |first1=Alka |last2=Singh |first2=Pratibha |last3=Awasthi |first3=Anshumali |last4=Verma |first4=Ritu |last5=Singh |first5=Anu T. |last6=Jaggi |first6=Manu |last7=Mishra |first7=Shiva Kant |last8=Kulkarni |first8=Sadanand |last9=Kulkarni |first9=Hrishikesh |journal=Clinical and Translational Oncology |volume=15 |issue=1 |pages=26–32 |pmid=22855169 }}
* {{cite journal |doi=10.1080/14756360802696802 |title=Anticancer and immunomodulatory activities of novel 1,8-naphthyridine derivatives |year=2009 |last1=Kumar |first1=Vivek |last2=Madaan |first2=Alka |last3=Sanna |first3=Vinod K. |last4=Vishnoi |first4=Manupriya |last5=Joshi |first5=Narendra |last6=Singh |first6=Anu T. |last7=Jaggi |first7=Manu |last8=Sharma |first8=Pramod K. |last9=Irchhaiya |first9=Raghuveer |last10=Burman |first10=Anand C. |journal=Journal of Enzyme Inhibition and Medicinal Chemistry |volume=24 |issue=5 |pages=1169–78 |pmid=19555167|display-authors=8 }}
* {{cite journal |pmid=19470292 |year=2009 |last1=Bansal |first1=Tripta |last2=Jaggi |first2=Manu |last3=Khar |first3=Roop K |last4=Talegaonkar |first4=Sushama |title=Emerging Significance of Flavonoids as P-Glycoprotein Inhibitors in Cancer Chemotherapy |volume=12 |issue=1 |pages=46–78 |journal=Journal of Pharmacy & Pharmaceutical Sciences |url=http://ejournals.library.ualberta.ca/index.php/JPPS/article/viewFile/4376/5218|citeseerx=10.1.1.557.474 }}

==External links==
* [http://www.daburresearch.in/ Official website]

{{Template:Dabur Group}}

{{Authority control}}

[[Category:Ayurvedic organisations]]
[[Category:Pharmaceutical companies of India]]
[[Category:Ghaziabad, Uttar Pradesh]]
[[Category:Medical research in India]]
[[Category:Pharmaceutical companies established in 1979]]
[[Category:Science and technology in Uttar Pradesh]]

{{India-org-stub}}